My Quote Request
6505-01-155-9430
20 Products
NDC00049-1201-83
CEFOPERAZONE SODIUM,USP
NSN, MFG P/N
6505011559430
NSN
6505-01-155-9430
NDC00049-1201-83
CEFOPERAZONE SODIUM,USP
NSN, MFG P/N
6505011559430
NSN
6505-01-155-9430
MFG
ROERIG DIV PFIZER INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1 GM. CEFOPERAZONE EQUIV. OF BASE IN VIAL
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFOPERAZONE SODIUM STERILE USP 1GM VIAL 10S PG
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: POWDER SUFFICIENT TO YIELD 1 GM. CEFOPERAZONE
PRIMARY CONTAINER TYPE: VIAL
TOTAL SECONDARY CONTAINER QUANTITY: 10
Related Searches:
NDC00359-0150-40
CYCLANDELATE CAPSULES
NSN, MFG P/N
6505011553633
NSN
6505-01-155-3633
NDC00359-0150-40
CYCLANDELATE CAPSULES
NSN, MFG P/N
6505011553633
NSN
6505-01-155-3633
MFG
ROANE BARKER DBA CALIGOR SOUTH EAST DIV CALIGOR MID-ATLANTIC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS CYCLANDELATE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 1000.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00078-0072-05
CLEMASTINE FUMARATE TABLETS,USP
NSN, MFG P/N
6505011554064
NSN
6505-01-155-4064
NDC00078-0072-05
CLEMASTINE FUMARATE TABLETS,USP
NSN, MFG P/N
6505011554064
NSN
6505-01-155-4064
MFG
SANDOZ INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS CLEMASTINE FUMARATE EQUIVALENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLEMASTINE FUMARATE TABLETS 2.68 MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: EA TABLET CONTAINS 2.68 MG CLEMASTINE FUMARATE
Related Searches:
NDC00093-0308-01
CLEMASTINE FUMARATE TABLETS,USP
NSN, MFG P/N
6505011554064
NSN
6505-01-155-4064
NDC00093-0308-01
CLEMASTINE FUMARATE TABLETS,USP
NSN, MFG P/N
6505011554064
NSN
6505-01-155-4064
MFG
LEMMON CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS CLEMASTINE FUMARATE EQUIVALENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLEMASTINE FUMARATE TABLETS 2.68 MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: EA TABLET CONTAINS 2.68 MG CLEMASTINE FUMARATE
Related Searches:
NDC00781-1359-01
CLEMASTINE FUMARATE TABLETS,USP
NSN, MFG P/N
6505011554064
NSN
6505-01-155-4064
NDC00781-1359-01
CLEMASTINE FUMARATE TABLETS,USP
NSN, MFG P/N
6505011554064
NSN
6505-01-155-4064
MFG
BRISTOL-MYERS CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS CLEMASTINE FUMARATE EQUIVALENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLEMASTINE FUMARATE TABLETS 2.68 MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: EA TABLET CONTAINS 2.68 MG CLEMASTINE FUMARATE
Related Searches:
TAVIST
CLEMASTINE FUMARATE TABLETS,USP
NSN, MFG P/N
6505011554064
NSN
6505-01-155-4064
TAVIST
CLEMASTINE FUMARATE TABLETS,USP
NSN, MFG P/N
6505011554064
NSN
6505-01-155-4064
MFG
SANDOZ INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS CLEMASTINE FUMARATE EQUIVALENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLEMASTINE FUMARATE TABLETS 2.68 MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: EA TABLET CONTAINS 2.68 MG CLEMASTINE FUMARATE
Related Searches:
2B1163P
DEXTROSE AND SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505011554079
NSN
6505-01-155-4079
2B1163P
DEXTROSE AND SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505011554079
NSN
6505-01-155-4079
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROSE AND SODIUM CHLORIDE INJECTION USP 500ML BAG 18S
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: W/OVERPOUCH AS WATER VAPOR BARRIER; TRANSPARENT FLEXIBLE BAG W/HANGER STRAP
TOTAL PRIMARY CONTAINER QUANTITY: 18
Related Searches:
NDC00046-0933-99
MAGALDRATE ORAL SUSPENSION,USP
NSN, MFG P/N
6505011554171
NSN
6505-01-155-4171
NDC00046-0933-99
MAGALDRATE ORAL SUSPENSION,USP
NSN, MFG P/N
6505011554171
NSN
6505-01-155-4171
MFG
WYETH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 96.000 MILLIGRAMS MAGALDRATE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: CUP,PATIENT
TOTAL PRIMARY CONTAINER QUANTITY: 100
Related Searches:
RIOPAN SUSPENSION
MAGALDRATE ORAL SUSPENSION,USP
NSN, MFG P/N
6505011554171
NSN
6505-01-155-4171
RIOPAN SUSPENSION
MAGALDRATE ORAL SUSPENSION,USP
NSN, MFG P/N
6505011554171
NSN
6505-01-155-4171
MFG
WYETH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 96.000 MILLIGRAMS MAGALDRATE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: CUP,PATIENT
TOTAL PRIMARY CONTAINER QUANTITY: 100
Related Searches:
NDC00074-1531-02
LIDOCAINE HYDROCHLORIDE AND DEXTROSE INJECTION
NSN, MFG P/N
6505011555081
NSN
6505-01-155-5081
NDC00074-1531-02
LIDOCAINE HYDROCHLORIDE AND DEXTROSE INJECTION
NSN, MFG P/N
6505011555081
NSN
6505-01-155-5081
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 0.400 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, GLASS
Related Searches:
NDC00074-1540-02
LIDOCAINE HYDROCHLORIDE AND DEXTROSE INJECTION
NSN, MFG P/N
6505011555082
NSN
6505-01-155-5082
NDC00074-1540-02
LIDOCAINE HYDROCHLORIDE AND DEXTROSE INJECTION
NSN, MFG P/N
6505011555082
NSN
6505-01-155-5082
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 0.800 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, GLASS
Related Searches:
NDC00004-6202-01
NAPROXEN SODIUM TABLETS,USP
NSN, MFG P/N
6505011555157
NSN
6505-01-155-5157
NDC00004-6202-01
NAPROXEN SODIUM TABLETS,USP
NSN, MFG P/N
6505011555157
NSN
6505-01-155-5157
MFG
ROCHE LABORATORIES INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 275.000 MILLIGRAMS NAPROXEN SODIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NAPROXEN SODIUM TABLETS USP 275MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00093-0536-01
NAPROXEN SODIUM TABLETS,USP
NSN, MFG P/N
6505011555157
NSN
6505-01-155-5157
NDC00093-0536-01
NAPROXEN SODIUM TABLETS,USP
NSN, MFG P/N
6505011555157
NSN
6505-01-155-5157
MFG
TEVA PHARMACEUTICALS USA INC. DBA GATE PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 275.000 MILLIGRAMS NAPROXEN SODIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NAPROXEN SODIUM TABLETS USP 275MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00143-9916-01
NAPROXEN SODIUM TABLETS,USP
NSN, MFG P/N
6505011555157
NSN
6505-01-155-5157
NDC00143-9916-01
NAPROXEN SODIUM TABLETS,USP
NSN, MFG P/N
6505011555157
NSN
6505-01-155-5157
MFG
WEST-WARD PHARMACEUTICAL CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 275.000 MILLIGRAMS NAPROXEN SODIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NAPROXEN SODIUM TABLETS USP 275MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
FOTAR
COAL TAR CREAM
NSN, MFG P/N
6505011555909
NSN
6505-01-155-5909
MFG
ELDER PHARMACEUTICALS INC
Description
ACTIVE INGREDIENT AND STRENGTH: 16.000 COAL TAR GRAMS
MEDICAMENT BASE TYPE: EMULSION BASE, WATER-IN-OIL
PRIMARY CONTAINER CONTENT QUANTITY: 3.000 OUNCES
PRIMARY CONTAINER TYPE: TUBE, PLASTIC SQUEEZE
Related Searches:
NDC00163-0373-03
COAL TAR CREAM
NSN, MFG P/N
6505011555909
NSN
6505-01-155-5909
MFG
ELDER PHARMACEUTICALS INC
Description
ACTIVE INGREDIENT AND STRENGTH: 16.000 COAL TAR GRAMS
MEDICAMENT BASE TYPE: EMULSION BASE, WATER-IN-OIL
PRIMARY CONTAINER CONTENT QUANTITY: 3.000 OUNCES
PRIMARY CONTAINER TYPE: TUBE, PLASTIC SQUEEZE
Related Searches:
ILOPAN-CHOLINE
DEXPANTHENOL AND CHOLINE BITARTRATE TABLETS
NSN, MFG P/N
6505011557988
NSN
6505-01-155-7988
ILOPAN-CHOLINE
DEXPANTHENOL AND CHOLINE BITARTRATE TABLETS
NSN, MFG P/N
6505011557988
NSN
6505-01-155-7988
MFG
ERBAMONT INC ADRIA LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS DEXPANTHENOL ACTIVE INGREDIENT AND 25.000 MILLIGRAMS CHOLINE BITARTRATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00013-2311-17
DEXPANTHENOL AND CHOLINE BITARTRATE TABLETS
NSN, MFG P/N
6505011557988
NSN
6505-01-155-7988
NDC00013-2311-17
DEXPANTHENOL AND CHOLINE BITARTRATE TABLETS
NSN, MFG P/N
6505011557988
NSN
6505-01-155-7988
MFG
ERBAMONT INC ADRIA LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS DEXPANTHENOL ACTIVE INGREDIENT AND 25.000 MILLIGRAMS CHOLINE BITARTRATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
0858
CEFOPERAZONE SODIUM,USP
NSN, MFG P/N
6505011559430
NSN
6505-01-155-9430
MFG
ROERIG DIV PFIZER INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1 GM. CEFOPERAZONE EQUIV. OF BASE IN VIAL
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFOPERAZONE SODIUM STERILE USP 1GM VIAL 10S PG
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: POWDER SUFFICIENT TO YIELD 1 GM. CEFOPERAZONE
PRIMARY CONTAINER TYPE: VIAL
TOTAL SECONDARY CONTAINER QUANTITY: 10
Related Searches:
CEFOBID
CEFOPERAZONE SODIUM,USP
NSN, MFG P/N
6505011559430
NSN
6505-01-155-9430
MFG
ROERIG DIV PFIZER INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1 GM. CEFOPERAZONE EQUIV. OF BASE IN VIAL
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFOPERAZONE SODIUM STERILE USP 1GM VIAL 10S PG
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: POWDER SUFFICIENT TO YIELD 1 GM. CEFOPERAZONE
PRIMARY CONTAINER TYPE: VIAL
TOTAL SECONDARY CONTAINER QUANTITY: 10